Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05030818 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cross-over Study of Coronary Risk Factors With a Polypill

Study acronym: POLICROSS
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 5, 2025 (before its estimated March 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Jun 30, 2025 to Mar 30, 2026 Completion date: Dec 30, 2026 to Apr 30, 2026v7 Show 1 more changeShow less
    • Completion date: Dec 30, 2026 to Apr 30, 2026
  2. Primary completion date: Dec 30, 2024 to Jun 30, 2025 Completion date: Dec 30, 2024 to Dec 30, 2026v6 Show 1 more changeShow less
    • Completion date: Dec 30, 2024 to Dec 30, 2026
  3. Primary and study completion dates: Sep 30, 2024 to Dec 30, 2024v5
  4. Lead sponsor: Fundación para la Investigación Biosanitaria del Principado de Asturias to Fundación EPIC Primary completion date: Jun 30, 2023 to Sep 30, 2024 · Completion date: Sep 30, 2023 to Sep 30, 2024v4 Show 2 more changesShow less
    • Primary completion date: Jun 30, 2023 to Sep 30, 2024
    • Completion date: Sep 30, 2023 to Sep 30, 2024
  5. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Sep 30, 2022 to Oct 14, 2022 · Site details revisedv3 Show 2 more changesShow less
    • Start date changed from estimate of Sep 30, 2022 to Oct 14, 2022
    • Site details revised
  6. Primary completion date: Jul 31, 2022 to Jun 30, 2023 Start date: Nov 1, 2021 to Sep 30, 2022 · Completion date: Aug 31, 2022 to Sep 30, 2023v2 Show 2 more changesShow less
    • Start date: Nov 1, 2021 to Sep 30, 2022
    • Completion date: Aug 31, 2022 to Sep 30, 2023
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Open-label, randomized, cross-over study conducted in a single center, applied to patients receiving a polypill with 100 mg of acetyl salicylic acid and different doses of ramipril and atorvastatin for indication of secondary prevention according to clinical practice, with objective of analyzing the level of systolic blood pressure and LDL-cholesterol in the same patient in 2 different periods: one under treatment of 3 months with the polypill and another of 3 months with the components separately.
Trial Details
NCT Number NCT05030818
Lead Sponsor Fundación EPIC
Conditions Coronary Artery Disease
Enrollment 88 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov